As of January 22, 2025, Compass Therapeutics (CMPX) has a market cap of $0.35 billion USD. According to our data, Compass Therapeutics is ranked No.6497 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.35 B |
77.93%
|
Dec 31, 2024 | $0.20 B |
-7.05%
|
Dec 29, 2023 | $0.21 B |
-68.99%
|
Dec 30, 2022 | $0.69 B |
58.68%
|
Dec 31, 2021 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Market Cap | = | CMPX Stock Price | * | CMPX Shares Outstanding |
= | $2.58 | * | 0.14 B | |
= | $0.35 B |